Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Phospho-MAP2K4-S257 is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
MAP2K4 |
Gene ID: |
6416 |
Uniprot ID: |
MP2K4_HUMAN |
Immunogen: |
A synthetic phosphorylated peptide around S257 of human MAP2K4 (NP_003001.1). |
Immunogen Sequence: |
VDSIA |
Tissue Specificity | Abundant expression is seen in the skeletal muscle. It is also widely expressed in other tissues. |
Post Translational Modifications | Activated by phosphorylation on Ser-257 and Thr-261 by MAP kinase kinase kinases (MAP3Ks). |
Function | Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to pro-inflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14. |
Protein Name | Dual Specificity Mitogen-Activated Protein Kinase Kinase 4Map Kinase Kinase 4Mapkk 4Jnk-Activating Kinase 1Mapk/Erk Kinase 4Mek 4Sapk/Erk Kinase 1Sek1Stress-Activated Protein Kinase Kinase 1Sapk Kinase 1Sapkk-1Sapkk1C-Jun N-Terminal Kinase Kinase 1Jnkk |
Database Links | Reactome: R-HSA-2559580Reactome: R-HSA-2871796Reactome: R-HSA-450321Reactome: R-HSA-5210891Reactome: R-HSA-5684264 |
Cellular Localisation | CytoplasmNucleus |
Alternative Antibody Names | Anti-Dual Specificity Mitogen-Activated Protein Kinase Kinase 4 antibodyAnti-Map Kinase Kinase 4 antibodyAnti-Mapkk 4 antibodyAnti-Jnk-Activating Kinase 1 antibodyAnti-Mapk/Erk Kinase 4 antibodyAnti-Mek 4 antibodyAnti-Sapk/Erk Kinase 1 antibodyAnti-Sek1 antibodyAnti-Stress-Activated Protein Kinase Kinase 1 antibodyAnti-Sapk Kinase 1 antibodyAnti-Sapkk-1 antibodyAnti-Sapkk1 antibodyAnti-C-Jun N-Terminal Kinase Kinase 1 antibodyAnti-Jnkk antibodyAnti-MAP2K4 antibodyAnti-JNKK1 antibodyAnti-MEK4 antibodyAnti-MKK4 antibodyAnti-PRKMK4 antibodyAnti-SEK1 antibodyAnti-SERK1 antibodyAnti-SKK1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance